Ann: Sonic Acquires 19.9% Microba Stake and Enters Partnership, page-27

On the Genova point I was repeating what was stated on a webinar.
Time is needed for each distributor to build its own market for microbiome testing services. It doesn't just go bang from day 1.
The distribution deals negotiated through out the world are with globally significant established businesses who are spending significant amounts of their own money in making sure the promotion and execution of the gut testing services are a success.
I may well be too conservative on my numbers.
I think the Genova opportunity in the USA is larger than the Sonic opportunity. Sonic gets the most press because its a large successful Australian company that everyone in Australia knows the name of. Nobody here would have heard of Genova.

On the second point of the IBD Phase 1 success and subsequent licensing fees as are word for word from the Cannacord analysts research report which is available on the Microba website for all to see.

Cheers